ConcertAI is an AI-powered SaaS data company that develops medical research tools in oncology.
ConcertAI has raised $150.0M in total funding. The most recent round was Series C. The last funding was announced in March 2022.
ConcertAI's investors include Plug and Play, Sixth Street, Maverick Ventures, Declaration Partners, AllianceBernstein.
ConcertAI is headquartered in Cambridge, United States.
ConcertAI is an AI-powered SaaS data company that develops medical research tools in oncology.
ConcertAI is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ConcertAI — Funding & Investors." VCBacked, March 29, 2022, https://www.vcbacked.co/company/concertai. Accessed August 14, 2026.
VCBacked. (2022). ConcertAI — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/concertai
{{cite web |title=ConcertAI — Funding & Investors |url=https://www.vcbacked.co/company/concertai |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated